Medtronic's Guardian Mobile CGM app, yet to be released in the US.
Despite speculations to the contrary from analysts last year, it looks like Medtronic will continue to acquire early-stage health companies even after its Covidien acquisition. On a fourth quarter earnings call, Medtronic CEO Omar Ishrak told analysts that the company would use new cash from the Covidien deal to invest in early...
